Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1478 of 6351
-
Can less chemo keep bladder cancer in check? new trial investigates
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the effectiveness of pembrolizumab monotherapy following 24 weeks of frontline pembrolizumab \& Enfortumab Vedotin (PEV) in patients with metastatic urothelial cancer (mUC).
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New depression pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New shot aims to ease arthritis pain in 30-Patient trial
Disease control OngoingThis study is ongoing to explore the efficacy and safety of different strengths of SHR-3045 injection in moderate to severe active rheumatoid arthritis.
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Weight-Loss drug may boost IVF success for overweight women
Symptom relief Recruiting nowThis is a randomized, controlled clinical trial with a two-sided superiority hypothesis. The study evaluates whether a 12-week pre-treatment with semaglutide prior to ovarian stimulation improves the number of good-quality blastocysts in overweight and obese women undergoing in v…
Phase 4 • Sponsor: Fundacion Dexeus • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Spinal cord stimulation study aims to fine-tune movement without surgery
Knowledge-focused Recruiting nowSpinal cord injury leads to long-lasting impairment, and currently, there is no cure for paralysis. Although transcutaneous spinal cord stimulation has shown promising results in recovering lost movements, its poor selectivity in muscle recruitment compared to invasive approaches…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can East-Meet-West medicine slow spine damage in ankylosing spondylitis?
Disease control Recruiting nowThis study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to eva…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Spotting the warning signs of drug-resistant epilepsy in children
Knowledge-focused PausedThis prospective cohort study evaluates clinical, electroencephalographic predictors of drug-resistant epilepsy in children. Predictive statistical and machine-learning models will be developed to facilitate early identification of children at high risk for drug-resistant epileps…
Sponsor: Pham Ngoc Thach University of Medicine • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
A patch-like device zaps a leg nerve to calm an overactive bladder
Symptom relief Recruiting nowA Post-Market Prospective Clinical Investigation to collect PMCF data on the safety and performance of the Cefar URO device when using the preset program P4 (parameter setting: frequency 20Hz, pulse width 200μs) for the symptomatic treatment of urge incontinence in adults with ov…
Sponsor: DJO UK Ltd • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Heart failure drug combo aims to cut hospital stays
Disease control Not yet recruitingThe goal of this clinical study is to evaluate whether adding finerenone to standard treatment with a sodium-glucose cotransporter-2 (SGLT2) inhibitor provides additional benefits in patients with heart failure. The main question this study aims to answer is whether the combinat…
Phase 4 • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Belly fat and colon cancer: which surgery works best?
Disease control Recruiting nowThis study aims to elucidate whether there is a difference in long-term prognosis between laparoscopic surgery and open surgery in colon cancer patients with visceral obesity.
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a single dose of esketamine calm severe depression during breast cancer surgery?
Symptom relief Not yet recruitingThis project employs a prospective, randomized, controlled, blinded, dual-center study design to investigate the effects of intraoperative esketamine on perioperative anxiety and depression symptoms in patients with severe depression undergoing breast cancer surgery.
Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New breath and blood tests could speed up lung disease diagnosis
Diagnosis Recruiting nowPatients with interstitial lung diseases (ILD) suffer significant delays in obtaining a diagnosis, and objective evidence of support for immunosuppressive therapies, due to weaknesses in the diagnostic tests available in ILD clinics. This project will assess several non-invasive…
Sponsor: University of Dundee • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Diet showdown: mediterranean vs paleo for arthritis relief
Disease control Recruiting nowThis study aims to evaluate the effects of Mediterranean and Paleolithic dietary interventions on nutritional status, disease activity, fatigue, sleep, and quality of life in adults with rheumatoid arthritis (RA). Participants aged 40-60 years will be randomly assigned to follow …
Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a headset at home boost brain recovery? new study tests tDCS for stroke, tumors, and neurodegeneration
Symptom relief OngoingThe purpose of this study is to assess the feasibility of home-based Transcranial Direct Current Stimulation (tDCS) combined with a home activity based therapy program in patients with stroke, brain tumors or neurodegenerative conditions and to assess the efficacy of home-based t…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo may keep severe colitis patients out of the hospital
Disease control Recruiting nowThis trial is being conducted to learn more about the optimal sequence of various medications in the management of acute severe ulcerative colitis (ASUC). This research is studying multiple drugs already approved by the Food and Drug Administration (FDA). The goal of this study …
Phase 4 • Sponsor: Berinstein, Jeffrey • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could electromagnetic fields help fight breast cancer?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced or metastatic HR positive, HER2 negative breast cancer who have progressed on standard of care options can affect patients survival. The main questions it aims to answer are: …
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New vaccine trial aims to shield vulnerable children from pneumonia
Vaccine Recruiting nowThis clinical trial evaluates the immunogenicity (humoral and cellular) and safety of the 20-valent pneumococcal conjugate vaccine (PCV20) in children, adolescents, and young adults aged 2-25 years with autoimmune rheumatic diseases (ARDs). All participants will receive PCV20 acc…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Vaccine
Last updated Jun 27, 2026 09:11 UTC
-
New hope for hard-to-treat colon cancer? trial launches for MSS patients.
Disease control Recruiting nowThis clinical study is testing whether a new combination of medicines (DSP107 and atezolizumab) is more effective and safer than an existing treatment (fruquintinib) for people with advanced colorectal cancer that is microsatellite stable (MSS). Participants will be randomly assi…
Phase 2 • Sponsor: Kahr Bio Australia Pty Ltd • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Which biologic best stops Crohn's from coming back after surgery?
Disease control Recruiting nowThis retrospective cohort study aims to compare the efficacy of different biologics in preventing postoperative endoscopic recurrence in Crohn's disease (CD). It plans to include 198 adult patients who underwent bowel resection and initiated prophylactic biologic therapy between …
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo targets recurrent ovarian cancer in small trial
Disease control OngoingThis is a multicenter, open-label study to evaluate the preliminary efficacy of SKB264 and the effect of clarithromycin on the PK of SKB264 in patients with ovarian epithelial cancer.
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC